drugset / Trial / NCT01136954

A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)

NCT01136954

Phase 3 Completed 144 enrolled Eisai Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the long-term safety and efficacy of zonisamide used as an adjunctive treatment in pediatric subjects treated with 1 or 2 other anti-epileptic drugs (AEDs).

Timeline

Start
2008-07
Primary completion
2012-01
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Zonisamide Other / unclassified 1 mg/kg Oral
Subject Zonisamide Other / unclassified 8 mg/kg Oral

Indications